Answer
Transient proteinuria after intravenous bolus or short-term administration of 5 g Praxbind (idarucizumab) is a physiological reaction to renal protein overflow, not an indication of kidney damage, which should be considered when testing urine.
Sources for this answer
- Praxbind 2.5 g/50 mL solution for injection/infusionBoehringer Ingelheim Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 12Document updated
Sources checked